Dual therapy stent

Dual Therapy Stent
Intervention
The Combo Dual Therapy Stent (OrbusNeich)

A dual therapy stent is a coronary artery stent that combines the technology of a bioengineered stent and a drug eluting stent to both accelerate endothelial coverage (healing of the vessel) and to block cell proliferation, thereby reducing the risk of restenosis.^[1]

The Combo Dual Therapy Stent (OrbusNeich) is the only dual therapy stent available today. It combines the Genous endothelial progenitor cell capture technology with an antiproliferative, biodegradable sirolimus drug elution.^[2] The Combo Stent has received CE Mark approval^[3] in Europe and was shown to be as effective as a paclitaxel-eluting stent in controlling neointimal hyperplasia.^[4]

References

1. Dual-Therapy Stenting: The Next Step in the Evolution of Stent Design (Cardiology Today: Intervention)
2. London, Susan (14 November 2011). "Bioengineered, Sirolimus-Eluting Stent Found ‘Safe,’ and ‘Effective.’" Cardiology News.
3. First Dual-Therapy Stent Nets CE Mark (Cardiology Today’s Intervention)
4. TCT: Combo Stent Comparable to Taxus (MedPage Today)

External links

• The COMBO Dual Therapy Stent